Dr Kathlyn Ronaldson - Researcher Profile

Biography

Kathlyn is a Senior Research Fellow. She is currently completing a case-control study designed to identify risk factors for myocarditis with the atypical antipsychotic clozapine. The final step is the genetic analysis. In addition, she has teaching responsibilities for two units in the Bachelor of Health Sciences, Treatments and Technologies and Disease Prevention and Control.

Prior to joining DEPM, Kathlyn spent 17 years in adverse drug reactions, firstly for the regulator in New Zealand, and then in Australia as Secretary of ACRAC. Kathlyn's educational background is organic chemistry, with a DPhil from the University of Waikato, Hamilton, New Zealand.

Qualifications

MASTER OF PUBLIC HEALTH

Institution: Monash University

Year awarded: 2011

DOCTOR OF PHILOSOPHY

Institution: University of Waikato, Hamilton, New Zealand

Year awarded: 1980

MASTER OF SCIENCE SECOND CLASS FIRST DIVISION

Institution: University of Waikato, Hamilton, New Zealand

Year awarded: 1977

BSC

Institution: University of Waikato, Hamilton, New Zealand

Year awarded: 1975

Publications

Journal Articles

Ronaldson, K.J., Lam, L.L.Y., Rodrigo, S., Tonkin, A.M., 2012, A meta-analysis of haemorrhage with ticlopidine and clopidogrel following coronary artery stent placement, European Journal of Cardiovascular Medicine [E], vol 11, issue 11, Healthcare Bulletin, United Kingdom, pp. 98-104.

Ronaldson, K.J., Fitzgerald, P.B., Taylor, A.J., Topliss, D.J., McNeil, J.J., 2012, Clozapine-induced myocarditis and baseline echocardiography, Australian And New Zealand Journal Of Psychiatry [P], vol 46, issue 10, Sage Publications, United Kingdom, pp. 1006-1007.

Ronaldson, K.J., Fitzgerald, P.B., Taylor, A.J., Topliss, D.J., McNeil, J.J., 2012, Clozapine-induced myocarditis and baseline echocardiography, Australian And New Zealand Journal Of Psychiatry [P], vol 46, issue 10, Sage Publications Ltd, London UK, pp. 1006-1007.

Ronaldson, K.J., Fitzgerald, P.B., Taylor, A.J., McNeil, J.J., 2012, Continuation of clozapine following mild myocarditis, Australian And New Zealand Journal Of Psychiatry [P], vol L, Sage Publications Ltd., United Kingdom, pp. 1-2.

Ronaldson, K.J., Fitzgerald, P.B., Taylor, A.J., McNeil, J.J., 2012, Observations from 8 cases of clozapine rechallenge after development of myocarditis, Journal of Clinical Psychiatry [P], vol 73, issue 2, Physicians Postgraduate Press, United States, pp. 252-254.

Ronaldson, K.J., Fitzgerald, P.B., Taylor, A.J., Topliss, D.J., Wolfe, R.S.J., McNeil, J.J., 2012, Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study, Schizophrenia Research [P], vol 141, issue 2-3, Elsevier BV, Netherlands, pp. 173-178.

Ronaldson, K., Fitzgerald, P., Taylor, A., Topliss, D., McNeil, J., 2011, A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls, Australian And New Zealand Journal Of Psychiatry [P], vol 45, issue 6, Informa Healthcare, United Kingdom, pp. 458-465.

Ronaldson, K., Fitzgerald, P., Taylor, A., Topliss, D., McNeil, J., 2011, Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases, Schizophrenia Research [P], vol 128, issue 1-3, Elsevier BV, Netherlands, pp. 161-165.

Ronaldson, K., 2011, Maintaining and enhancing the value of spontaneous reporting programmes, Pharmaceutical Medicine [P], vol 25, issue 2, Adis International Ltd, New Zealand, pp. 83-86.

Ronaldson, K., Taylor, A., Fitzgerald, P., Topliss, D., Elsik, M., McNeil, J., 2010, Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls, Journal of Clinical Psychiatry [P], vol 71, issue 8, Physicians Postgraduate Press Inc., United States, pp. 976-981.

McNeil, J., Piccenna, L., Ronaldson, K., Ioannides-Demos, L., 2010, The value of patient-centred registries in phase IV drug surveillance, Pharmaceutical Medicine [P], vol 24, issue 5, Adis International Ltd, New Zealand, pp. 281-288.

Ronaldson, K.J., McNeil, J.J., 2009, Improving drug safety by locating genetic markers for hypersensitivity reactions, Medical Journal Of Australia [P], vol 190, issue 11, Australasian Medical Publishing Company Pty. Ltd, Australia, pp. 641-643.

Ronaldson, K.J., 2009, The new age of pharmacovigilance, Medical Journal Of Australia [P], vol 191, issue 3, Australasian Medical Publishing Company Pty. Ltd, Australia, pp. 132-134.

Ronaldson, K.J., O'Shea, J.M., Boyd, I.W., 2006, Risk factors for rhabdomyolysis with simvastatin and atorvastatin, Drug Safety, vol 29, issue 11, Adis International Ltd, New Zealand, pp. 1061-1067.

Ronaldson, K.J., Boyd, I., 2006, Risk factors for rhabdomyolysis with simvastatin and atorvastatin: Author's reply, Drug Safety, vol 29, issue 12, Adis International Ltd, New Zealand, pp. 1191-1192.

Isaacs, D., Lawrence, G., Boyd, I., Ronaldson, K.J., McEwen, J., 2005, Reporting of adverse events following immunization in Australia, Journal of Paediatrics and Child Health, vol 41, issue 4, Wiley-Blackwell Publishing Ltd, United Kingdom, Australia, pp. 163-166.